Form 8-K - Current report:
SEC Accession No. 0001005286-25-000014
Filing Date
2025-01-07
Accepted
2025-01-07 09:07:21
Documents
15
Period of Report
2025-01-07
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20250107.htm   iXBRL 8-K 26306
2 EX-99.1 a2025-01x07form8xkex991.htm EX-99.1 12691
6 image_0a.jpg GRAPHIC 51460
  Complete submission text file 0001005286-25-000014.txt   237697

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20250107.xsd EX-101.SCH 1864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20250107_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20250107_pre.xml EX-101.PRE 12591
17 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20250107_htm.xml XML 2690
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 25513578
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)